Relay Therapeutics (RLAY) Retained Earnings (2019 - 2026)
Relay Therapeutics (RLAY) reported Retained Earnings of -$172000.0 for Q1 2026, up 99.99% year-over-year from -$86004.1 in Q1 2025, and up 99.99% quarter-over-quarter from -$2.0 billion in Q4 2025.
Relay Therapeutics (RLAY) Retained Earnings (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Retained Earnings data on file, last reported at -$172000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$172000.0, up 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$172000.0 (up 99.99% YoY), and the FY2025 annual result was -$2.0 billion, down 203206.66% from the prior year.
- Retained Earnings advanced to -$172000.0 in Q1 2026 per RLAY's latest filing, from -$2.0 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $2.5 million in Q3 2024 and troughed at -$2.0 billion in Q4 2025.
- A 5-year average of -$833.7 million and a median of -$991.1 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 100.19% in 2024, then plunged 203206.66% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$1.1 billion in 2022, then slumped by 32.3% to -$1.4 billion in 2023, then jumped by 99.93% to -$991000.0 in 2024, then sank by 203206.66% to -$2.0 billion in 2025, then jumped by 99.99% to -$172000.0 in 2026.
- Business Quant data shows RLAY's Retained Earnings at -$172000.0 in Q1 2026, -$2.0 billion in Q4 2025, and -$2.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | -172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -2.01 Bn |
| Sep 30, 2025 | -2.00 Bn |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | -1.82 Bn |
| Dec 31, 2024 | -991,000.00 |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | -1.34 Mn |
| Mar 31, 2024 | -1.50 Bn |
| Dec 31, 2023 | -1.40 Bn |
| Sep 30, 2023 | -1.32 Bn |
| Jun 30, 2023 | -6.08 Mn |
| Mar 31, 2023 | -1.15 Bn |
| Dec 31, 2022 | -1.06 Bn |
| Sep 30, 2022 | -991.11 Mn |
| Jun 30, 2022 | -906.93 Mn |
| Mar 31, 2022 | -9.22 Mn |
| Dec 31, 2021 | -768.10 Mn |
| Sep 30, 2021 | -700.64 Mn |
| Jun 30, 2021 | -639.81 Mn |